Latest News for: Lonza Group

Edit

Cell Culture Market Expected to Rise Total Valuation of US$ 75 Billion by The End of 2032

Pharmiweb 12 May 2022
Cell culture has become an essential aspect of vaccine manufacture in the pharmaceutical business ... The primary critical players in the market are Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories ... .
Edit

Insights on the Stem Cell Therapy Global Market to 2027 - Ongoing Advancements in Regenerative ...

Eagle-Tribune 12 May 2022
... Co., Ltd.Lonza Group AGMedipost Co., Ltd.Nuvasive, Inc.Osiris Therapeutics, Inc.Pharmicell Co., Ltd.Pluristem Therapeutics Inc.PromoCell GmbHRTI Surgical, Inc.STEMCELL Technologies, Inc.Takeda Pharmaceutical Company LimitedVericel CorporationVistaGen Therapeutics, Inc.
Edit

Global Contract Development & Manufacturing Organization (CDMO) Market Insights & Forecasts 2022-2026 with Potential Impact of COVID-19 - ResearchAndMarkets.com

Pharmiweb 11 May 2022
DUBLIN--(BUSINESS WIRE)--The "Global Contract Development & Manufacturing Organization (CDMO) Market ... The company profiles of leading players (Catalent, Inc., Recipharm AB, Evotec SE, Lonza Group AG, Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail ... 1 ... Evotec SE Lonza Group AG Recipharm AB Thermo Fisher Scientific Inc.
Edit

Global Contract Development & Manufacturing Organization (CDMO) Market Insights & Forecasts 2022-2026 with Potential Impact ...

The Galveston Daily News 11 May 2022
DUBLIN--(BUSINESS WIRE)--May 11, 2022-- ... The company profiles of leading players (Catalent, Inc., Recipharm AB, Evotec SE, Lonza Group AG, Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail. Key Topics Covered.. 1. Introduction. 1. CDMO ... Biomerieux SACatalent, Inc.Evotec SELonza Group AGRecipharm ABThermo Fisher Scientific Inc.
Edit

Global Aseptic Pharma Processing Market Report to 2027 - by Component, Technology, Product, Application and Region - ResearchAndMarkets.com

Pharmiweb 11 May 2022
DUBLIN--(BUSINESS WIRE)--The "Global Aseptic Pharma Processing Market, By Component, By Technology, By Product, By Application, By Region, Competition Forecast and Opportunities, 2017-2027" report has been added to ResearchAndMarkets.com's offering ... Years Considered for This Report. Historical Years ... 2023F-2027F ... Lonza Group Baxter International Inc ... .
Edit

Global Exosome Research Products Market Research Report to 2027 - Featuring BioCat, BioVision, Fujifilm Holdings and HiSS Diagnostics Among Others - ResearchAndMarkets.com

Pharmiweb 11 May 2022
The Global Exosome Research Products Market size was estimated at USD 129.77 million in 2021, USD 145.31 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.15% to reach USD 258.30 million by 2027 ... 1 ... 2 ... 3 ... 4 ... 5 ... 1 ... Lonza Group AG Malvern Panalytical Ltd MBL International Corporation Miltenyi Biotec GmbH NanoSomiX, Inc.
Edit

Global Exosome Research Products Market Research Report to 2027 - Featuring BioCat, BioVision, Fujifilm Holdings ...

Eagle-Tribune 11 May 2022
Companies MentionedAMSBIO LLCBeckman Coulter, Inc.Bio-Techne CorporationBioCat GmbHBioVision Inc.Fujifilm Holdings CorporationHiSS Diagnostics GmbHHitachi Chemical Diagnostics Inc.Lonza Group AGMalvern Panalytical LtdMBL International CorporationMiltenyi Biotec GmbHNanoSomiX, ...
Edit

Lonza Expands its Capsugel® Capsule Offering to Include Titanium Dioxide-Free White Hard Gelatin Capsules (Lonza Group Ltd)

Public Technologies 09 May 2022
Basel, Switzerland, 09 May 2022 - Lonza has expanded its Capsugel® offering with a titanium dioxide-free (TiO2-free) white hard gelatin capsule, fulfilling the evolving demand of its customers to meet new titanium dioxide-free requirements for foods in the European Union ... Lonza Group Ltd.
Edit

Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms (Lonza Group Ltd)

Public Technologies 09 May 2022
It will also provide a unique opportunity for ALSA Ventures' portfolio companies to leverage Lonza's experience in supporting accelerated development and manufacturing projects, global network and regulatory competence ... Pnina Weitz, Global Head of Venture Capital Business Development and Relationship Management, Lonza, commented ... Lonza Group Ltd.
Edit

United States Pharmaceutical Contract Manufacturing Organization Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - ResearchAndMarkets.com

Pharmiweb 09 May 2022
The stricter regulation in the country ensures the superior quality of the manufacturing and the end-product that is being adhered to by the CMOs ... (Patheon Inc.) Boehringer Ingelheim Group Pfizer CentreSource (Pfizer Inc.) Aenova Group AbbVie Contract Manufacturing Baxter Biopharma Solutions (Baxter International Inc.) Lonza Group AG Siegfried AG ... .
Edit

United States Pharmaceutical Contract Manufacturing Organization Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 ...

Eagle-Tribune 09 May 2022
DUBLIN--(BUSINESS WIRE)--May 9, 2022-- ... This approval and drug-developing pipelines are expected to promise more opportunities to CMOs in the future ... (Patheon Inc.)Boehringer Ingelheim GroupPfizer CentreSource (Pfizer Inc.)Aenova GroupAbbVie Contract ManufacturingBaxter Biopharma Solutions (Baxter International Inc.)Lonza Group AGSiegfried AG ... SOURCE.
Edit

3D Cell Culture Market 2022 Value With Status And Global Analysis Thermo Fisher Scientific, Corning, ...

MENA FN 07 May 2022
(MENAFN - Ameliorate Solutions) Posted on May 7, 2022 by Viviana Jackson 3D Cell Culture Market 2022 Value with Status and Global AnalysisThermo Fisher Scientific, Corning, Lonza Group, Kuraray ... .
Edit

Niacin and Niacinamide Market Key Players – Lonza Group AG, Koninklijke DSM N.V., Bactolac Pharmaceutical Inc, Merck KGaA, BASF SE

Pharmiweb 06 May 2022
According to a group of researchers from University of Sydney, niacinamide has showcased photo-protective effects against melanoma development mechanisms ... Elder population with cardiovascular diseases, under age-group 50-80, who consumed extended release niacin and laropiprant (to ...
Edit

Lonza Announces Results of the 2022 Annual General Meeting – All Motions Proposed by Board of Directors Accepted (Lonza Group Ltd)

Public Technologies 05 May 2022
Basel, Switzerland, 5 May 2022 - Today, Lonza Group Ltd hosted its Annual General Meeting (AGM), led by the Chairman of the Board of Directors, Albert M ... In addition, the Board of Directors of the Lonza Group has decided to initiate in Q2 2022 a tender for the ... Lonza Group Ltd.

Most Viewed

President Joe Biden signs S. 583, the “Promoting Rigorous and Innovative Cost Efficiencies for Federal Procurement and Acquisitions Act of 2021” or the “PRICE Act of 2021,” Tuesday, February 22, 2022, in the Oval Office at the White House.
White House / Adam Schultz
×